Anaphylaxis to apple and orange seed - 30/11/11
Doi : 10.1016/j.jaci.2011.07.005
Paul J. Turner, FRACP, PhD a, b 
, Paul E.A. Gray, FRACP a, Melanie Wong, FRACP, PhD a, Nirupama Varese, MSc c, Jennifer M. Rolland, PhD c, Robyn O’Hehir, FRACP, PhD c, Dianne E. Campbell, FRACP, PhD a, b
, Paul E.A. Gray, FRACP a, Melanie Wong, FRACP, PhD a, Nirupama Varese, MSc c, Jennifer M. Rolland, PhD c, Robyn O’Hehir, FRACP, PhD c, Dianne E. Campbell, FRACP, PhD a, b a Department of Allergy and Immunology, Children’s Hospital at Westmead, Sydney, Australia
b Discipline of Pediatrics and Child Health, School of Medicine, University of Sydney, Sydney, Australia
c Department of Immunology, Monash University, Melbourne, Australia
| Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest. |
© 2011
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 128 - N° 6
P. 1363-1365 - décembre 2011 Retour au numéro
Article précédent
- A novel mutation in CD132 causes X-CID with defective T-cell activation and impaired humoral reactivity
- Taco W. Kuijpers, Paul A. Baars, Daan J. aan de Kerk, Machiel H. Jansen, Ingrid A.M. Derks, Robbert G.M. Bredius, Elisabeth A.M. Sanders, Mirjam van der Burg, Marielle Alders, Rene A.W. van Lier
- T-cell involvement in delayed-type hypersensitivity reactions to infliximab
- Maria Jose Torres, Patrícia Chaves, Inmaculada Doña, Natalia Blanca-López, Gabriela Canto, Cristobalina Mayorga, Miguel Blanca
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?